Onco Therapy Science, Inc operates within the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Onco Therapy Science, Inc with three other
companies in this sector in Japan:
Chiome Bioscience Inc
sales of 212.85 million Japanese Yen [US$1.90 million]
of which 99%
was base plate technolgy license business),
3-D Matrix Ltd
(228.62 million Japanese Yen [US$2.04 million]
of which 100%
was Medical Products), and
Oncolys Biopharma Inc
(168.55 million Japanese Yen [US$1.51 million]
During the year ended March of 2018, sales at
Onco Therapy Science, Inc were ¥211.25 million (US$1.89 million).
decrease of 26.3%
versus 2017, when the company's sales were ¥286.67 million.